Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Disease Markers
Volume 2016 (2016), Article ID 4703854, 6 pages
http://dx.doi.org/10.1155/2016/4703854
Research Article

RANTES Gene Polymorphisms Associated with HIV-1 Infections in Kenyan Population

1Institute of Tropical Medicine and Infectious Diseases, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya
2Institute of Biotechnology, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya
3Department of Plant and Microbial Sciences, Kenyatta University, Nairobi, Kenya
4Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya

Received 21 April 2016; Revised 5 August 2016; Accepted 9 August 2016

Academic Editor: Giuseppe Murdaca

Copyright © 2016 Shem P. M. Mutuiri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Cocchi, A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso, “Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells,” Science, vol. 270, no. 5243, pp. 1811–1815, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. W. A. Paxton, A. U. Neumann, S. Kang et al., “RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression,” Journal of Infectious Diseases, vol. 183, no. 11, pp. 1678–1681, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. D. Kelly, H. M. Naif, S. L. Adams, A. L. Cunningham, and A. R. Lloyd, “Cutting edge: dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages,” Journal of Immunology, vol. 160, no. 7, pp. 3091–3095, 1998. View at Google Scholar · View at Scopus
  4. A. Kinter, A. Catanzaro, J. Monaco et al., “CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4+ T cells: role of signal transduction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 20, pp. 11880–11885, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Saha, G. Bentsman, L. Chess, and D. J. Volsky, “Endogenous production of β-chemokines by CD4+, but not CD8+ T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro,” Journal of Virology, vol. 72, no. 1, pp. 876–881, 1998. View at Google Scholar · View at Scopus
  6. W. A. Paxton, S. Kang, R. Liu et al., “HIV-1 infectability of CD4+ lymphocytes with relation to β-chemokines and the CCR5 coreceptor,” Immunology Letters, vol. 66, no. 1–3, pp. 71–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. W. A. Paxton, S. R. Martin, D. Tse et al., “Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures,” Nature Medicine, vol. 2, no. 4, pp. 412–417, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Suresh, A. Wanchu, A. Bhatnagar, R. K. Sachdeva, and M. Sharma, “Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India,” AIDS Research and Human Retroviruses, vol. 23, no. 2, pp. 261–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. O. Clegg, L. J. Ashton, R. A. Biti et al., “CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors,” AIDS, vol. 14, no. 2, pp. 103–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Samson, F. Libert, B. J. Doranz et al., “Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene,” Nature, vol. 382, no. 6593, pp. 722–725, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. W. He, S. Neil, H. Kulkarni et al., “Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility,” Cell Host and Microbe, vol. 4, no. 1, pp. 52–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Duggal, C. A. Winkler, P. An et al., “The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users,” Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 5, pp. 584–589, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Liu, T. Shioda, Y. Nagai et al., “Distribution of HIV-1 disease modifying regulated on activation normal T cell expressed and secreted haplotypes in Asian, African and Caucasian individuals. French ALT and IMMUNOCO Study Group,” AIDS, vol. 13, no. 18, pp. 2602–2603, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Liu, D. Chao, E. E. Nakayama et al., “Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 8, pp. 4581–4585, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. P. An, G. W. Nelson, L. Wang et al., “Modulating influence on HIV/AIDS by interacting RANTES gene variants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 15, pp. 10002–10007, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. McDermott, M. J. Beecroft, C. A. Kleeberger et al., “Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study,” AIDS, vol. 14, no. 17, pp. 2671–2678, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Wichukchinda, E. E. Nakayama, A. Rojanawiwat et al., “Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females,” AIDS, vol. 20, no. 2, pp. 189–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Koizumi, S. Kageyama, Y. Fujiyama et al., “RANTES 28G delays and DCSIGN 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs,” AIDS Research and Human Retroviruses, vol. 23, no. 5, pp. 713–719, 2007. View at Publisher · View at Google Scholar
  19. E. Gonzalez, R. Dhanda, M. Bamshad et al., “Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5199–5204, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-Y. Zhao, S. S. Lee, K. H. Wong et al., “Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese,” European Journal of Immunogenetics, vol. 31, no. 4, pp. 179–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. G. S. Cooke, K. Tosh, P. A. Ramaley et al., “A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease,” Journal of Infectious Diseases, vol. 194, no. 5, pp. 666–669, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Vidal, J. Peraire, P. Domingo et al., “Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years,” Journal of Acquired Immune Deficiency Syndromes, vol. 41, no. 1, pp. 17–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Nyamache, A. W. T. Muigai, Z. Nganga, and S. A. Khamadi, “HIV type 1 genetic diversity and naturally occurring polymorphisms in HIV type 1 Kenyan isolates: implications for integrase inhibitors,” AIDS Research and Human Retroviruses, vol. 28, no. 8, pp. 933–936, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Khamadi, W. Ochieng, R. W. Lihana et al., “HIV type 1 subtypes in circulation in northern Kenya,” AIDS Research and Human Retroviruses, vol. 21, no. 9, pp. 810–814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Kameyoshi, A. Dörschner, A. I. Mallet, E. Christophers, and J.-M. Schröder, “Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils,” Journal of Experimental Medicine, vol. 176, no. 2, pp. 587–592, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. A. H. Al Hajeer, F. Al Sharif, and W. E. R. Ollier, “A polymorphism at position −403 in the human RANTES promoter,” European Journal of Immunogenetics, vol. 26, no. 5, pp. 375–376, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Ai Sharif, W. E. R. Ollier, and A. H. Hajeer, “A rare polymorphism at position −28 in the human RANTES promoter,” European Journal of Immunogenetics, vol. 26, no. 5, pp. 373–374, 1999. View at Publisher · View at Google Scholar
  28. A. Rathore, A. Chatterjee, P. Sivarama, N. Yamamoto, P. K. Singhal, and T. N. Dhole, “Association of RANTES −403 G/A, −28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians,” Journal of Medical Virology, vol. 80, no. 7, pp. 1133–1141, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Katz, G. C. John-Stewart, B. A. Richardson et al., “CCR5, RANTES and SDF-1 polymorphisms and mother-to-child HIV-1 transmission,” International Journal of Immunogenetics, vol. 37, no. 4, pp. 301–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. M. Fernandez, S. Borrego, I. Marcos, A. Rubio, E. Lissen, and G. Antinolo, “Fluorescence resonance energy transfer analysis of the RANTES polymorphisms -403GA and -28GC: evaluation of both variants as susceptibility factors to HIV type 1 infection in the Spanish population,” AIDS Research and Human Retroviruses, vol. 19, no. 5, pp. 349–352, 2003. View at Publisher · View at Google Scholar
  31. L. Vangelista, M. Secchi, and P. Lusso, “Rational design of novel HIV-1 entry inhibitors by RANTES engineering,” Vaccine, vol. 26, no. 24, pp. 3008–3015, 2008. View at Publisher · View at Google Scholar · View at Scopus